These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32067463)

  • 1. Mosaic Cooperativity in Slow Polypeptide Topological Isomerization Revealed by Residue-Specific NMR Thermodynamic Analysis.
    Fujinami D; Motomura H; Oshima H; Mahin AA; Elsayed KM; Zendo T; Sugita Y; Sonomoto K; Kohda D
    J Phys Chem Lett; 2020 Mar; 11(5):1934-1939. PubMed ID: 32067463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residue-Specific Kinetic Insights into the Transition State in Slow Polypeptide Topological Isomerization by NMR Exchange Spectroscopy.
    Fujinami D; Hayashi S; Kohda D
    J Phys Chem Lett; 2021 Nov; 12(43):10551-10557. PubMed ID: 34694122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The time-zero HSQC method improves the linear free energy relationship of a polypeptide chain through the accurate measurement of residue-specific equilibrium constants.
    Hayashi S; Kohda D
    J Biomol NMR; 2022 Jun; 76(3):87-94. PubMed ID: 35699866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping and identification of the region and secondary structure required for the maturation of the nukacin ISK-1 prepeptide.
    Nagao J; Morinaga Y; Islam MR; Asaduzzaman SM; Aso Y; Nakayama J; Sonomoto K
    Peptides; 2009 Aug; 30(8):1412-20. PubMed ID: 19481127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel type of immunity protein, NukH, for the lantibiotic nukacin ISK-1 produced by Staphylococcus warneri ISK-1.
    Aso Y; Okuda K; Nagao J; Kanemasa Y; Thi Bich Phuong N; Koga H; Shioya K; Sashihara T; Nakayama J; Sonomoto K
    Biosci Biotechnol Biochem; 2005 Jul; 69(7):1403-10. PubMed ID: 16041148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative transport between NukFEG and NukH in immunity against the lantibiotic nukacin ISK-1 produced by Staphylococcus warneri ISK-1.
    Okuda K; Aso Y; Nakayama J; Sonomoto K
    J Bacteriol; 2008 Jan; 190(1):356-62. PubMed ID: 17951378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the nukacin KQU-131, a new type-A(II) lantibiotic produced by Staphylococcus hominis KQU-131 isolated from Thai fermented fish product (Pla-ra).
    Wilaipun P; Zendo T; Okuda K; Nakayama J; Sonomoto K
    Biosci Biotechnol Biochem; 2008 Aug; 72(8):2232-5. PubMed ID: 18685189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a gene cluster of Staphylococcus warneri ISK-1 encoding the biosynthesis of and immunity to the lantibiotic, nukacin ISK-1.
    Aso Y; Sashihara T; Nagao J; Kanemasa Y; Koga H; Hashimoto T; Higuchi T; Adachi A; Nomiyama H; Ishizaki A; Nakayama J; Sonomoto K
    Biosci Biotechnol Biochem; 2004 Aug; 68(8):1663-71. PubMed ID: 15322349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction to "Mosaic Cooperativity in Slow Polypeptide Topological Isomerization Revealed by Residue-Specific NMR Thermodynamic Analysis".
    Fujinami D; Motomura H; Oshima H; Mahin AA; Elsayed KM; Zendo T; Sugita Y; Sonomoto K; Kohda D
    J Phys Chem Lett; 2021 Nov; 12(44):10766-10767. PubMed ID: 34714649
    [No Abstract]   [Full Text] [Related]  

  • 10. LiaRS reporter assay: A simple tool to identify lipid II binding moieties in lantibiotic nukacin ISK-1.
    Elsayed KM; Islam MR; Abdullah-Al-Mahin ; Nagao JI; Zendo T; Sonomoto K
    J Biosci Bioeng; 2017 Mar; 123(3):398-401. PubMed ID: 27856233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel lantibiotic, nukacin ISK-1, of Staphylococcus warneri ISK-1: cloning of the structural gene and identification of the structure.
    Sashihara T; Kimura H; Higuchi T; Adachi A; Matsusaki H; Sonomoto K; Ishizaki A
    Biosci Biotechnol Biochem; 2000 Nov; 64(11):2420-8. PubMed ID: 11193411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ring A of nukacin ISK-1: a lipid II-binding motif for type-A(II) lantibiotic.
    Islam MR; Nishie M; Nagao J; Zendo T; Keller S; Nakayama J; Kohda D; Sahl HG; Sonomoto K
    J Am Chem Soc; 2012 Feb; 134(8):3687-90. PubMed ID: 22329487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering.
    Nagao J; Aso Y; Shioya K; Nakayama J; Sonomoto K
    J Mol Microbiol Biotechnol; 2007; 13(4):235-42. PubMed ID: 17827974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nukacin 3299, a lantibiotic produced by Staphylococcus simulans 3299 identical to nukacin ISK-1.
    Ceotto H; Holo H; da Costa KF; Nascimento Jdos S; Salehian Z; Nes IF; Bastos Mdo C
    Vet Microbiol; 2010 Nov; 146(1-2):124-31. PubMed ID: 20627619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Description of complete DNA sequence of two plasmids from the nukacin ISK-1 producer, Staphylococcus warneri ISK-1.
    Aso Y; Koga H; Sashihara T; Nagao J; Kanemasa Y; Nakayama J; Sonomoto K
    Plasmid; 2005 Mar; 53(2):164-78. PubMed ID: 15737403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding specificity of the lantibiotic-binding immunity protein NukH.
    Okuda K; Yanagihara S; Shioya K; Harada Y; Nagao J; Aso Y; Zendo T; Nakayama J; Sonomoto K
    Appl Environ Microbiol; 2008 Dec; 74(24):7613-9. PubMed ID: 18978082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of osmotic stress on the production of nukacin ISK-1 from Staphylococcus warneri ISK-1.
    Sashihara T; Dan M; Kimura H; Matsusaki H; Sonomoto K; Ishizaki A
    Appl Microbiol Biotechnol; 2001 Aug; 56(3-4):496-501. PubMed ID: 11549026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysine-oriented charges trigger the membrane binding and activity of nukacin ISK-1.
    Asaduzzaman SM; Nagao J; Aso Y; Nakayama J; Sonomoto K
    Appl Environ Microbiol; 2006 Sep; 72(9):6012-7. PubMed ID: 16957223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro catalytic activity of N-terminal and C-terminal domains in NukM, the post-translational modification enzyme of nukacin ISK-1.
    Shimafuji C; Noguchi M; Nishie M; Nagao J; Shioya K; Zendo T; Nakayama J; Sonomoto K
    J Biosci Bioeng; 2015 Dec; 120(6):624-9. PubMed ID: 25971839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of functional domains of lantibiotic-binding immunity protein, NukH, from Staphylococcus warneri ISK-1.
    Okuda K; Aso Y; Nagao J; Shioya K; Kanemasa Y; Nakayama J; Sonomoto K
    FEMS Microbiol Lett; 2005 Sep; 250(1):19-25. PubMed ID: 16009508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.